Episurf Medical carries out a directed share issue of SEK 159 million. Ilija Batljan enters as new large shareholder
This press release may not be made public, published or distributed, directly or indirectly, within or to the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or any other jurisdiction where such action would be unlawful or subject to legal restrictions.The Board of Directors of Episurf Medical AB (publ) (“Episurf Medical” or the “Company”) has, based on the authorisation granted by the Annual General Meeting on 10 May 2021, resolved on a directed issue of 44,408,108 shares of series B at an issue price of SEK 3.59 per share (the “Share